Clonal distribution and associated characteristics of Escherichia coli clinical and surveillance isolates from a military medical center - PubMed (original) (raw)
Clonal distribution and associated characteristics of Escherichia coli clinical and surveillance isolates from a military medical center
Amee R Manges et al. Diagn Microbiol Infect Dis. 2017 Apr.
Abstract
Antimicrobial-resistant Escherichia coli are a concern for military health services. We studied 100 extended-spectrum beta-lactamase (ESBL)-producing and non-producing E. coli clinical and surveillance isolates from military personnel and civilians at Brooke Army Medical Center (2007-2011). Major E. coli lineages, most prominently ST10 (24%), ST131 (16%), and ST648 (8%), were distributed much as reported for other North American populations. ST131, represented mainly by its resistance-associated ST131-H30 clonal subset, was uniquely associated with a clinical origin, regardless of ESBL status. Thus, clonal background predicted resistance phenotype and clinical versus surveillance origin, and these findings could assist military clinicians and epidemiologists.
Keywords: Antimicrobial resistance; Escherichia coli infections; Extended-spectrum beta-lactamases; Military medicine; Molecular epidemiology; Multilocus sequence typing; ST131; ST131-H30; Veterans; Virulence genes.
Published by Elsevier Inc.
Similar articles
- Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
Sherchan JB, Hayakawa K, Miyoshi-Akiyama T, Ohmagari N, Kirikae T, Nagamatsu M, Tojo M, Ohara H, Sherchand JB, Tandukar S. Sherchan JB, et al. Antimicrob Agents Chemother. 2015;59(6):3424-32. doi: 10.1128/AAC.00270-15. Epub 2015 Mar 30. Antimicrob Agents Chemother. 2015. PMID: 25824221 Free PMC article. - Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.
Lafolie J, Nicolas-Chanoine MH, Grenouillet F, Hocquet D, Bertrand X. Lafolie J, et al. Int J Antimicrob Agents. 2014 Nov;44(5):466-8. doi: 10.1016/j.ijantimicag.2014.07.016. Epub 2014 Sep 3. Int J Antimicrob Agents. 2014. PMID: 25241262 - Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.
Helldal L, Karami N, Welinder-Olsson C, Moore ER, Åhren C. Helldal L, et al. BMC Microbiol. 2017 Jan 6;17(1):8. doi: 10.1186/s12866-016-0922-1. BMC Microbiol. 2017. PMID: 28061803 Free PMC article. - CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
Ewers C, Bethe A, Stamm I, Grobbel M, Kopp PA, Guerra B, Stubbe M, Doi Y, Zong Z, Kola A, Schaufler K, Semmler T, Fruth A, Wieler LH, Guenther S. Ewers C, et al. J Antimicrob Chemother. 2014 May;69(5):1224-30. doi: 10.1093/jac/dkt516. Epub 2014 Jan 6. J Antimicrob Chemother. 2014. PMID: 24398338 - Current Trends in Antimicrobial Resistance of Escherichia coli.
Paitan Y. Paitan Y. Curr Top Microbiol Immunol. 2018;416:181-211. doi: 10.1007/82_2018_110. Curr Top Microbiol Immunol. 2018. PMID: 30088148 Review.
Cited by
- Increase in the Rate of Gut Carriage of Fluoroquinolone-Resistant Escherichia coli despite a Reduction in Antibiotic Prescriptions.
Tchesnokova V, Larson L, Basova I, Sledneva Y, Choudhury D, Heng J, Solyanik T, Bonilla T, Pham S, Schartz E, Madziwa L, Holden E, Weissman S, Ralston J, Sokurenko E. Tchesnokova V, et al. Res Sq [Preprint]. 2023 Jan 12:rs.3.rs-2426668. doi: 10.21203/rs.3.rs-2426668/v1. Res Sq. 2023. PMID: 36712036 Free PMC article. Updated. Preprint. - Genetic and Virulence Characteristics of a Hybrid Atypical Enteropathogenic and Uropathogenic Escherichia coli (aEPEC/UPEC) Strain.
Valiatti TB, Santos FF, Santos ACM, Nascimento JAS, Silva RM, Carvalho E, Sinigaglia R, Gomes TAT. Valiatti TB, et al. Front Cell Infect Microbiol. 2020 Sep 29;10:492. doi: 10.3389/fcimb.2020.00492. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33134184 Free PMC article. - Molecular Epidemiology and Presence of Hybrid Pathogenic Escherichia coli among Isolates from Community-Acquired Urinary Tract Infection.
Nascimento JAS, Santos FF, Santos-Neto JF, Trovão LO, Valiatti TB, Pinaffi IC, Vieira MAM, Silva RM, Falsetti IN, Santos ACM, Gomes TAT. Nascimento JAS, et al. Microorganisms. 2022 Jan 27;10(2):302. doi: 10.3390/microorganisms10020302. Microorganisms. 2022. PMID: 35208757 Free PMC article. - Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.
Manges AR, Geum HM, Guo A, Edens TJ, Fibke CD, Pitout JDD. Manges AR, et al. Clin Microbiol Rev. 2019 Jun 12;32(3):e00135-18. doi: 10.1128/CMR.00135-18. Print 2019 Jun 19. Clin Microbiol Rev. 2019. PMID: 31189557 Free PMC article. - Increase in the community circulation of ciprofloxacin-resistant Escherichia coli despite reduction in antibiotic prescriptions.
Tchesnokova V, Larson L, Basova I, Sledneva Y, Choudhury D, Solyanik T, Heng J, Bonilla TC, Pham S, Schartz EM, Madziwa LT, Holden E, Weissman SJ, Ralston JD, Sokurenko EV. Tchesnokova V, et al. Commun Med (Lond). 2023 Aug 12;3(1):110. doi: 10.1038/s43856-023-00337-2. Commun Med (Lond). 2023. PMID: 37567971 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical